A

Ascidian Therapeutics

RNA exon editing for gene therapies

Associate Director - Program Management

Program ManagementPosted on Nov 13
Part-timeBoston, MA, USANo salary listedIn-person

About the Job

Requirements

  • A bachelor's degree in a scientific or engineering discipline, such as Biology, Biochemistry, Pharmaceutical Sciences, or Chemical Engineering, or a related field.
  • At least 7 years of experience in the biopharmaceutical or life sciences industry, including at least 4 years of program or project management supporting drug development programs.
  • Proven experience moving a program through IND-enabling studies and IND submission.
  • Working knowledge of nonclinical development, including GLP toxicology, biodistribution, and pharmacology, and of CMC for biologics.
  • Experience identifying and managing program risks, assessing critical-path implications, and proactively addressing issues that could affect program timelines or deliverables.
  • Ability to influence cross-functional stakeholders at all levels without direct authority, including CROs and external development partners.
  • Strong decision-making skills, including framing options, assessing trade-offs, and guiding teams toward clear, data-driven decisions.
  • Demonstrated experience coordinating and managing work with CROs and CDMOs, including vendor selection, contract and work order management, and ongoing vendor oversight.
  • Proficiency with Smartsheet or comparable project management software, and comfort building integrated timelines, risk registers, and dashboards.
  • Ability to work independently and deliver effectively in a part-time contract capacity of approximately 20 hours per week, with interest in a potential transition to full-time.

Responsibilities

  • Own the integrated program plan and timeline across research, CMC, regulatory, and clinical-readiness activities, including the critical path and key dependencies.
  • Build and maintain program plans, trackers, and dashboards in Smartsheet, and implement scalable project management practices suited to a growing company.
  • Act as the team's point person on program risk by proactively identifying issues, driving mitigations and contingency plans with functional leads, and escalating issues as needed.
  • Coordinate cross-functional input into agency interactions such as IND filings, including tracking timelines, review cycles, and commitments.
  • Drive external activities with CROs and CDMOs, integrate their work into the program plan, and hold partners accountable for high-quality deliverables.
  • Serve as a point of contact as needed for vendor and contract management, from vendor selection and contracting through day-to-day relationship management.
  • Organize and lead program team meetings, capture decisions and action items, and keep the team focused on priorities.
  • Present program status, trade-offs, and options to program leads and the leadership team to support timely decisions.
  • Support budget planning, forecasting, and resource tracking, and flag variances and reprioritization needs.
  • Deliver clear program updates and dashboards to the team and leadership, and maintain program documentation and decision logs.

Desired Qualifications

  • An advanced degree (MS, PhD, or PharmD).
  • Experience with AAV or other gene therapy programs, including viral vector manufacturing and analytics.
  • Experience supporting INTERACT or pre-IND meetings and coordinating IND module authoring.
  • Strong proficiency with Smartsheet.
  • PMP or other project management certification.

About the Company

Ascidian Therapeutics

RNA exon editing for gene therapies

Ascidian Therapeutics focuses on RNA exon editing to treat diseases. It develops technologies that edit RNA transcripts after they are made from DNA, enabling precise changes while keeping natural gene expression patterns. This approach aims to produce full-length, functional proteins and offer durable therapeutic effects without direct DNA editing or gene replacement. The company monetizes by licensing its RNA exon editing technology to healthcare providers and research institutions and may also participate in development and sale of therapies based on its platform. Compared with competitors, it emphasizes transcriptome re-engineering in human cells to achieve steady gene expression without altering the genome, reducing certain genetic risks while maintaining normal regulatory control. The overall goal is to translate RNA exon editing into accessible therapies for patients by partnering for licensing and therapy development.

Company size
11-50
Company stage
Series A
Total funding
$90M
Headquarters
Boston, MA
Founded
2020

Recently Posted Jobs

Explore more opportunities at Ascidian Therapeutics

See more jobs